Search Results

A discovery by Stanford Medicine researchers and colleagues may pave the way for a “morning after” or prophylactic nasal spray to prevent infection.

A new study has identified a way that the immune system shoots down its own cells when their anti-viral activity threatens to become friendly fire. The finding could pave the way to new treatments for autoimmune diseases.

New medications help many people with inflammatory conditions and may ease severe COVID-19, but they carry risks.

Stanford pediatricians helped conduct clinical trials of COVID-19 vaccines for children. Data from the study will be submitted to the Food and Drug Administration for consideration.

In a study of mRNA-based COVID-19 vaccine doses given at Stanford Medicine, vaccine allergies were rare, mild and mostly triggered by a vaccine additive, not the mRNA.

Release of the brain’s equivalent of THC, marijuana’s active component, reduces seizure activity but leads to post-seizure oxygen deprivation in the brain, Stanford scientists and their collaborators have shown.

Scientists have discovered a simple method of reformulating gentamicin, a commonly used and highly effective antibiotic, that could reduce the risk it poses of causing deafness.

The Stanford researcher is pursuing antiviral drugs with broad efficacy against enteroviruses, which cause common colds and polio, and coronaviruses including the one that causes COVID-19.